Home | Speakers | Agenda | Satellite Course | Venue | Delegates | Sponsors | Media | Register

Confirmed speakers include:

                BustinStephen Bustin
Professor of Allied Health and Medicine
Anglia Ruskin University, UK

Stephen Bustin obtained his PhD in molecular genetics from Trinity College, University of Dublin and is currently Professor of Allied Health and Medicine at Anglia Ruskin University in the UK. He has authored numerous papers, review articles and book chapters aimed at improving the reproducibility and robustness of real-time PCR, and has the “A-Z of quantitative PCR” (2004), “The PCR Revolution” (2011) and “PCR Technology” (2013, with Tania Nolan). Professor Bustin was an expert witness advising the UK High Court on qPCR technology in the Measles Mumps Rubella (MMR) vaccine - Autism class action as well as at the MMR trial in Washington DC in 2007. He led an international consortium developing the MIQE guidelines for the use and reporting of qPCR (2009). Professor Bustin has extensive editorial involvements as Editor-in-Chief, Biomolecular Detection and Quantification (Elsevier) , Editor-in Chief (Gene Expression), International Journal of Molecular Sciences, and is a member of the editorial boards of “Nature Scientific Reports”,  “Gene Regulation and Systems Biology” and “ Biomarkers in Medicine”.

                StahlbergAnders Ståhlberg
Senior Scientist, Department of Pathology
University of Gothenburg, Sweden

Anders Ståhlberg, Associate Professor, is working as principal investigator at the Cancer Center, Sahlgrenska Academy, University of Gothenburg in Sweden. He has a PhD in molecular biotechnology and gene expression profiling and has performed two post-doc periods working with human embryonic stem cells, stem cell properties of astrocytes and human sarcomas. Anders primary research interest is to understand molecular mechanisms in tumor initiation, tumor development and stem cell differentiation. The research are focused on sarcomas caused by specific fusion oncogenes, but other tumor types are also studied. He has developed several strategies for gene expression profiling, especially at the single-cell level. Anders is also co-founder of TATAA Biocenter, Gothenburg, Sweden.

Jan RuijterJan Ruijter
Principle Investigator, Department of Anatomy, Embryology & Physiology, Academic Medical Centre
Amsterdam University, The Netherlands

Jan M Ruijter trained as a medical biologist and worked in endocrinology, neurobiology, ophthalmology and embryology. He is currently appointed as principle investigator in the department of Anatomy, Embryology & Physiology (Academic Medical Centre, Amsterdam, the Netherlands) where he is heading a research group studying the relation between gene expression and the development of the heart with molecular, image analysis and 3D reconstruction techniques. The statistical analysis of research data resulted in the development of the LinRegPCR program for the analysis quantitative PCR data based on PCR efficiency values derived from amplification curves (http://LinRegPCR.nl).

                HodzicEmir Hodzic
Director, Real-Time PCR Research & Diagnostic Core Facility
University of California, Davis, USA

Dr. Hodzic graduated from the Veterinary school at University of Sarajevo, then obtained Master degree and a Ph.D. degree that laid a foundation in the area of Microbiology and molecular biology. As a postdoctoral fellow at Yale, Dr. Hodzic research focused on investigating the interaction of Borrelia burgdorferi and Anaplasma phagocytophilum, with tick vectors and mammalian hosts, using animal models. In 1997 he got a faculty position at the Center for Comparative Medicine, at University of California at Davis. Currently he is serving as a Director of the Real-Time PCR Research and a diagnostic Core Facility at UC Davis, School of Veterinary Medicine. During his career Dr. Hodzic collaborated with other researchers, and produced numerous peer-reviewed publications from each project. Well grounded in academics, in research, and in experimental skills, Dr. Hodzic has demonstrated evidence of accomplishment, productivity, independence, collaboration, expertise and scientific abilities in the area of Microbiology and molecular biology.

                TalyValerie Taly
Group Leader/CNRS Researcher
CNRS/Université Paris-Descartes, France

After graduation as a Molecular Toxicologist (Paris-Descartes), Dr Taly (Abecassis) performed her PhD research at the Center of Molecular Genetics (CNRS, Gif-sur-Yvette, France) on applications of combinatorial methods (generally used for proteins directed evolution) to the study of the functional plasticity of human Cytochromes P450. She joined Andrew Griffiths’ group in 2003, in the Medical Research Council in Cambridge (UK), to work on in vitro compartmentalization of biological and chemical reactions in emulsion droplets and participated to the development of High-throughput selection procedures of double-emulsions by FACS. In 2005, she integrated the Laboratory of Biological Chemistry directed by Prof. Andrew Griffiths in the ISIS institute (Université de Strasbourg) as a permanent CNRS researcher in 2005 to work on HTS procedures using droplet-based microfluidics. Since 2008, she developed droplet-based digital procedures for Cancer diagnosis. Recently, her team developed a highly sensitive quantitative procedures for the detection of Cancer Biomarkers in droplets in a collaboration involving the clinical laboratory of Prof. P. Laurent-Puig (European Georges Pompidou Hospital, University Paris-Descartes), the team of Dr J.-C. Baret (Max Plank Institute) and Raindance Technologies (US). She is now Group Leader in the university Paris-Descartes. Her research is dedicated to the clinical validation of the developed droplet-based procedures for the non-invasive detection of Cancer biomarkers, the highlighting of new Cancer Biomarkers and the development of original tools and procedures for their detection with applications in personalized medicine, cancer recurrence detection and cancer diagnostics.

                DeMelloAndrew deMello
Professor of Biochemical Engineering, Department of Chemistry and Applied Biosciences, ETH Zürich
Professor of Bioengineering, MRC Clinical Sciences Centre, Imperial College London

Andrew is currently Professor of Biochemical Engineering in the Department of Chemistry and Applied Biosciences at ETH Zurich. He is also Professor of Bioengineering at the MRC Clinical Sciences Centre, Imperial College London.

He obtained a 1st Class Degree in Chemistry and PhD in Molecular Photophysics from Imperial College London in 1995 and subsequently held a Postdoctoral Fellowship in the Department of Chemistry at the University of California, Berkeley.

His research interests cover a broad range of activities in the general area of microfluidics and nanoscale science. Primary specializations include the development of microfluidic devices for high-throughput biological and chemical analysis, ultra-sensitive optical detection techniques, nanofluidic reaction systems for chemical synthesis, novel methods for nanoparticle synthesis, the exploitation of semiconducting materials in diagnostic applications, the development of intelligent microfluidics and the processing of living organisms.

Andrew has given approximately 250 invited lectures at international conferences and universities including 60 plenary or keynote lectures, has published 210 papers in refereed journals, and co-authored two books. He is also co-founder of Molecular Vision Ltd, an Imperial College spin-out company developing low-cost diagnostic devices for use in the doctor's surgery and in the home. Science originating from the deMello group has been recognized through the award of the 2002 SAC Silver Medal (Royal Society of Chemistry), the 2009 Clifford Paterson Medal from The Royal Society, the 2009 Corday Morgan Medal (Royal Society of Chemistry), the 2007 Clark Memorial Lectureship (California State University) and 2012 Pioneers of Miniaturisation Award (Dow Corning)

                GodfreyTony Godfrey
Associate Chair, Surgical Research, Associate Professor of Surgery
Boston University, USA

Tony E. Godfrey, PhD, Associate Chair for Surgical Research and Associate Professor of Surgery, Boston University School of Medicine, earned a bachelor’s of science degree in biochemistry from Brunel University in England, followed by a doctorate in molecular biology and biochemistry, also from Brunel. He attended the University of California, San Francisco, for postdoctoral fellowships followed by faculty appointments at the University of Pittsburgh, Mount Sinai Hospital, NY, and the University of Rochester Medical Center in Rochester, NY.

Dr. Godfrey’s research is focused on cancer genetics and molecular pathology. Research projects use state-of-the-art genetic and genomic approaches to address clinical needs in the areas of cancer diagnosis, prognosis and therapy. Currently the major focus of Dr. Godfrey’s research is on Barrett’s oesophagus and oesophageal adenocarcinoma. The Godfrey lab works closely with translational research teams comprised of surgeons, pathologists and oncologists in order to develop new molecular approaches to cancer detection, staging and treatment.

                Guldborg NyvoldCharlotte Guldborg Nyvold
Associate Professor, HemoDiagnostic Laboratory
Aarhus University Hospital, Denmark

Charlotte Guldborg Nyvold is Associate Professor at Aarhus University Hospital in Denmark.  She holds a Master of Science in Chemistry and Biotechnology from Aarhus University and has completed her Ph.D. studies at the Department of Clinical Immunology at the National University Hospital Rigshospitalet in Copenhagen.

For the past 20 years she has been working with quantification of minimal residual disease in haematological cancers using qPCR. She is a part of the diagnostic unit at the Molecular Genetic Section, Department of Haematology at Aarhus University Hospital where haematological neoplasms are being diagnosed and monitored using molecular biomarkers. Her research is presently focused on the characterisation of new molecular markers in monoclonal B-cell malignancies directed towards personalized diagnosis and prognosis.

David Rodriguez LazaroDavid Rodríguez-Lázaro
Assistant Professor of Microbiology
University of Burgos, Spain

Dr. David Rodríguez-Lázaro is a Doctor in Veterinary Medicine (DVM), specialised in Food Science (BSc and MSc) and Molecular Microbiology (PhD). He is senior scientist at ITACyL and assistant Professor of Microbiology at the University of Burgos. He has performed research stays in the Danish Institute for Food and Veterinary Research (Denmark), University of Prague (Czech Republic), the Food and Environmental Research Agency (UK), and the University of Bristol (UK). He was a Leverhulme visiting Professor in the Institute of Advanced Sciences in the University of Bristol during the years 2004 and 2005 and Marie Curie Research Fellow in the Faculty of Medical and Veterinary Sciences in the University of Bristol (UK) until 2.007. His research interest is focused on the development of emergent food preservation processes and their effects in the virulence and the establishment of reliable, quantitative molecular strategies for detection of important food-borne pathogens from environmental sources and various types of foodstuffs. He has participated in a number of coordinated European and Spanish projects such as PROMISE, BASELINE, VITAL, FOOD-PCR, SACROHN, and MONI-QA, having established active links with the leading European research groups working in Food Safety. He has published more than 75 international research papers and book or book chapters regarding to Food Safety. He is currently member of the editorial board of “Applied and Environmental Microbiology”, “International Journal of Food Microbiology” and “Food and Environmental Virology”, and the editor-in-chief of the Journal “Food Analytical Methods” edited by Springer.

                JenningsLawrence Jennings
Assistant Professor of Pathology ; Director, Molecular Pathology
Northwestern University/Ann and Robert H. Lurie Children's Hospital of Chicago, USA

Larry Jennings, MD, PhD, D(ABHI), FCAP, is an Assistant Professor in the Department of Pathology and Laboratory Medicine Northwestern University's Feinberg School of Medicine.  He is board-certificated in anatomic and clinical pathology, molecular genetic pathology, histocompatibility and immunogenetics.  He is director of HLA and molecular diagnostic laboratories at Ann and Robert H. Lurie Children’s Hospital of Chicago.  Dr. Jennings chairs the Molecular Oncology Resource Committee for the College of American Pathologists and has overseen the Minimal Residual Disease external quality assessment survey for the past 7 years.  His work with digital PCR has focused on clinical applications of the technology and includes publications on the use of droplet digital PCR for the detection of and quantification of microchimerism and minimal residual disease.

                Egea-CortinesMarcos Egea Gutiérrez-Cortines
Professor of Genetics
ETSIA, Spain

Marcos Egea-Cortines. Studied Biology at the University of Murcia (Spain).  He did his PhD at Ben-Gurion University (Israel) and post-doctoral studies at the Technion, Israel Institute of Technology. He was a post-doctoral Fellow of the Max-Planck Society (Plant Breeding Cologne). Associate professor of Genetics at the Universidad Politécnica de Cartagena, and Vicedirector of the Institute of Plant Biotecnology. He was a visiting professor at Purdue University (USA). Works in developmental genetics and is interested in regulation of growth and plant products by the genome and its interaction with the environment. The lab has a strong interest in the development of molecular technologies and methods related to Q-PCR, NGS, and automation of sample acquirement.

                SchroeperFlorian Schröper
Leader Research Field "Innovative Detection Technologies and Assay Designs"
Department of Plant Biotechnology
Fraunhofer Institute of Molecular Biology and Applied Ecology Aachen, Germany

Florian Schröper studied biology at RWTH Aachen University in Germany including an internship at the Fraunhofer Center for Molecular Biotechnology in Newark, Delaware, USA where he was involved in several projects focusing on molecular farming and plant biotechnology. He graduated in 2005 and subsequently started his PhD at the Institute of Bio- and Nanosystems at the Researchcenter Jülich, Germany. In his thesis he worked on strategies for functional protein immobilization to electrode surfaces for bioelectronical applications. He finished his PhD in 2009. Since then he worked at the Fraunhofer Institute of Molecular Biology and Applied Ecology in Aachen. As Postdoc he has been working in the department of plant biotechnology focusing on the development of different analytical approaches. Since 2012 he is responsible for the research field "Innovative Detection Technologies and Assay Designs" were he has established different immunological, qPCR and Next Generation Sequencing based detection and screening approaches for agricultural and plant biotechnological applications.

Peter MolloyPeter Molloy
Senior Principal Research Scientist, Preventative Health Flagship
Commonwealth Scientific and Industrial Research Organisation, Australia

Dr Molloy has over 30 years’ experience in molecular and cell biology and genetics, with a particular focus on epigenetics and the regulation of gene expression. He has made significant contributions to the development of technologies for analysis of DNA methylation, including bisulphite sequencing, selective amplification methods and novel methods of genome-wide analysis. As Leader of Colorectal Cancer Diagnostics within CSIRO’s Preventative Health Flagship, his major research role has been in identification and validation of molecular biomarkers and optimisation of methods for early detection of colorectal cancer. A set of DNA methylation biomarkers arising from this work has undergone validation in a large clinical trial. A diagnostic assay base on this collaborative program is being commercialised by partner Clinical Genomics Pty Ltd with launch in mid 2014.

                Feveile YoungJette Feveile Young
Associate Professor
Aarhus University, Denmark

Jette Feveile Young is an Associate Professor with the Institute of Food Science at Aarhus University where she is scientific leader for the Differentiated and Biofunctional Food Group.  She holds a Master of Food Science from the former Royal Veterinarian Agricultural University (now University of Copenhagen) as well as a PhD in Photo Biology from the University of Wales.  She returned to Denmark in 1996 to take a Post Doc position at the Institute of Human Nutrition at Copenhagen University investigating the nutritional effects of naturally occurring antioxidants.

She now pursues her research career with scientific focus on meat quality in relation to feeding, stress and slaughter conditions and partly on the biological functionality of food components using in vitro cell based models.

Joshua YuanJoshua Yuan
Associate Professor and Director
Texas A&M Agrilife Synthetic and Systems Biology Innovation Hub, Texas A&M University, USA

Dr. Joshua Yuan is an Associate Professor at Department of Plant Pathology and Microbiology and the Director for Texas A&M Agrilife Synthetic and Systems Biology Innovation Hub in Texas A&M University. He received his Ph.D. degree with focus areas on Functional Genomics (Major) and Statistics (Minor) from the University of Tennessee (2007). He also holds an M.S. in Plant Sciences from the University of Arizona (2001) and a B.S. in Biology (Major) and International Economics (Minor) from Fudan University (1997). Dr. Yuan developed an integrated and multidisciplinary research program centralized around systems and syntehtic biology, where latest ‘omics’ technologies were employed to address the challenging biological questions in biofuel development and to guide the biodesign of microbes and plants for the production of fuels, chemicals and nutriceuticals. Dr. Yuan also synergized the teaching and research with extensive scholarship and service activities in bioenergy and synthetic biology by serving as international conference committee chairs, journal associate editors, board of directors for scholar society, and scientific advisors for start-up companies in Texas and beyond.

DM PandeyDev Mani Pandey
Associate Professor, Department of Biotechnology
Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India

Dr. Dev Mani Pandey completed his Ph. D. in Plant Physiology and Biochemistry from Chaudhary Charan Singh, Haryana Agriculture University, Hisar, India. He was Post-Doctoral Fellow in Republic of South Korea and worked in the areas of Plant Molecular Biology and Functional Genomics. He was also invited as Consultant to Plant Breeding, Genetics and Biotechnology, IRRI, Los Banos, Philippines.

Dr. Pandey has presented his research findings in various National and International Symposia, Conferences and Congress as well as organized International Symposium successfully. He has published several research papers in peer reviewed journals. He is the Principal Investigator of Sponsored projects as well as Guide of many Ph. D. Scholars. His research areas and scientific expertise includes molecular biology, functional genomics, stress physiology and bioinformatics approaches on crop plants using recent biotechnological tools.

Tigst DemekeTigst Demeke
Research Scientist
Canadian Grain Commission, Canada

Tigst Demeke joined the Canadian Grain Commission (CGC) as a research scientist in April 2001. He received his Ph.D  from Colorado State University in horticulture/tissue culture. Tigst’s current research focuses on detection and identification of genetically modified grains and oilseeds. He also collaborates with the Grain Research Laboratory’s Microbiology program on the use of DNA-based molecular markers for identification and characterization of plant pathogens

                MasonDeborah Mason
Reader, School of Biosciences
Cardiff University, UK

After my BSc in Zoology and Genetics (1986) and my PhD in Evolutionary Genetics (1991) in Cardiff, I moved to Bristol University where my research revealed bone cell gene expression in vivo and implicated glutamatergic signalling in mechanically-induced bone formation. Since appointment in Cardiff University (Lecturer 1996, Senior Lecturer 2009, Reader 2012), I have investigated the role of glutamate transporters in bone, revealed a pathological role for glutamate in arthritis, and identified new pathways of cytokine- and mechanically- induced cartilage degradation. I have secured over £12M of research funding for 30 projects. I act as a manager, and as the Biomechanics, Inflammation and Pain Team Leader in the Arthritis Research UK-funded Centre of Excellence in Biomechanics and Bioengineering at Cardiff. I have supervised 11 PhD/MD students and teach undergraduate students, co-ordinating the Molecular Biology Degree Scheme in Cardiff. I regularly contribute to public engagement with school children, patients and fundraisers.

                BoyerMickaël Boyer
Team Leader - Analytical Microbiology & Molecular Biology
Danone, France

Mickaël Boyer, PhD, is Analytical Microbiology & Molecular Biology Team Leader for Danone Nutricia Research. From 2003 to 2008, he worked in academic as microbial ecologist (Lyon, France) to study use of plant probiotics as natural fertilizer to stimulate plant health. He developed expertises in molecular biology and microbiology. From 2008 to 2011, he held a scientific position in an academic infectious disease center (Marseille, France) and acquired experience in virology and metagenomic for application in human health. Since 2011, he develops analytical expertises in dairy microbiology to speed up innovation in Danone. He is a professional member of IDF (International Dairy Federation).

                MagnussonBjörn Magnusson
Senior Scientist, Cellular Reagents and Assay Development
AstraZeneca, Sweden

I am working with assay development within Reagents and Assay Development, Discovery Sciences. Since I joined AstraZeneca two years ago, I have been part of the general movement of replacing artifical cell models with biologically more relevant systems based on  primary or native cells. I have been working in target-based projects, as well as phenotypic screening activities. During the last year, my main focus has been adipocytes and quantitative PCR.

Before joining AstraZeneca I did a post-doc on adipocyte biology at Gothenburg University, followed by two years at NovoNordisk, Copenhagen, working with metabolic in-vitro assays.

                IonnidesMarios Ioannides
The Cyprus Institute of Neurology and Genetics, Cyprus

Marios Ioannides is a Researcher at the Translational Genomics Team at the Cyprus Institute of Neurology and Genetics. He had previously worked at the Department of Cytogenetic and Genomics for 7 years and  has extensive expertise in a range of molecular diagnostic assays including QFPCR , aCGH and digital PCR. He has also been working on the discovery of fetal specific biomarkers and their implementation in non-invasive prenatal diagnosis.

                CornerAdam S. Corner
Senior Field Application Scientist
RainDance Technologies

Adam S. Corner, Ph.D., has been with Raindance Technologies since March 2011, as a Senior Field Applications Scientist. Prior to RainDance Technologies Adam was with Ingenuity Systems (2004-2011) as a Senior Scientist, based in Europe. Before Ingenuity Systems, Adam was with the Application Support group at Applied Biosystems for 7 years. Adam studied for his Batchelor of Science in Biochemistry & Genetics at the University of Leeds, from 1987-1990. He continued at the University of Leeds from 1990-1993, earning a Ph.D. in molecular identification of nematodes.

                RodigerStefan Rödiger
Group Leader
BTU Cottbus – Senftenberg, Germany

Stefan Rödiger is group leader at the Brandenburg University of Technology Cottbus - Senftenberg. He studied pharma-biotechnology and holds a doctorate in Medical Sciences from the Charité, Berlin. Stefan worked at the University Hospital of Jena (Germay), University Hospital Dresden (Germany), MPI-CBG (Germany) and several small and medium-sized businesses. His research interests cover a broad range of activities including statistical bioinformatics and the development of novel multiparameter diagnostic tools for the accurate measurement of biomolecules from pathogens and autoimmune diseases. He is author of several R packages for the analysis of qPCR data, microbead assays, digital PCR data and melting curve analysis. Current studies focus on statistical bioinformatics for qPCR assays, dPCR assays, multipex real-time PCR microbead-chips and multiparameter diagnostics tools for the highly versatile fluorescence microscope-based VideoScan platform.

                O'GradyJustin O’Grady
Lecturer in Medical Microbiology
Norwich Medical School, University of East Anglia, UK

I gained my B.Sc. in Microbiology, my M.Sc. (Res) in infectious diseases molecular diagnostics and my Ph.D. in molecular diagnosis of bacterial pathogens in food all at the National University of Ireland Galway (NUIG).  My early career focussed on the molecular detection of pathogens in food using lab-on-a-chip technology and isothermal amplification based diagnostics. This was followed by a two year stint in industry (Beckman Coulter) developing real-time PCR based molecular diagnostics assays for infectious diseases including Mycobacterium tuberculosis. During my time at Beckman Coulter, I developed a strong interest in tuberculosis (TB) research, which inspired me to move back into academia and take up a post-doc position at University College London on TB diagnostics. In January 2013 I was appointed Lecturer in Medical Microbiology at UEA where I continue my research on microbial pathogen molecular diagnostics with the aim of translating this research broadly, in different sectors and diseases, to maximise community/patient benefit.

                PasternakAlexander Pasternak
Researcher, Laboratory of Experimental Virology
Amsterdam University Medical Center, The Netherlands

Dr. Pasternak received his PhD in Molecular Virology from the Leiden University, Netherlands. From 2006, he works as a Researcher in the Laboratory of Experimental Virology of the Amsterdam University Medical Center. His research focuses on persistence and evolution of HIV-1 reservoir in the face of antiretroviral therapy, in particular the development of sensitive PCR-based quantitative assays for virological biomarkers.

                MouliereFlorent Mouliere
Postdoctoral Research Associate, Cancer Research UK Cambridge Institute
University of Cambridge, UK

Florent completed his PhD from the University of Montpellier (France) in the field of non-invasive biomarkers and was implicated in the characterization of the size and structure of circulating tumour DNA (ctDNA). He was also involved in the development of a Q-PCR based assay for determining KRAS and BRAF mutations in plasma ctDNA. He moved to the Rosenfeld Lab of the Cancer Research UK Cambridge Institute afterwards to start his postdoctoral training, where he now works on exploring the potential of ctDNA as a tool for monitoring the efficacy of new therapeutics and the rise of resistance.

                CapassoMario Capasso
Assistant Professor
University of Naples Federico II, Italy

Yiu-Lian Fong
Division Vice President, R&D
Abbott Molecular, USA

Jim Huggett
Science Leader, Nucleic Acid Metrology, Molecular & Cell Biology

Brian Lockhart
Director, Molecular Pharmacology & Pathophysiology
Servier, France

Angelika Daser
Senior Scientist
SHGen Wiesbaden Fertility Center, Germany

Anna Wilbrey
Senior Scientist
Pfizer, UK

Sonja Venter
Research Institute Manager
Agricultural Research Council, South Africa

Claudia Paret
TRON - Translational Oncology
Johannes Gutenberg University of Mainz, Germany

More confirmed speakers and biographies to follow shortly.....

Register Now


About Global Engage  |  T&Cs  |  Agenda  |  Testimonials  |  Register

Copyright:  Global Engage Ltd.   Registered in England.  No: 6950636